{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:39:16Z","timestamp":1760888356864},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.semnephrol.2009.01.003","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T04:15:24Z","timestamp":1239768924000},"page":"105-112","source":"Crossref","is-referenced-by-count":8,"title":["Kidney Disease Outcomes Quality Initiative Guidelines for Bone and Mineral Metabolism: Emerging Questions"],"prefix":"10.1016","volume":"29","author":[{"given":"Tejas V.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2009.01.003_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2215\/CJN.01310307","article-title":"Bone and mineral guidelines for patients with chronic kidney disease: a call for revision","volume":"3","author":"Andress","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib3","series-title":"Method for evaluating research and guideline evidence (MERGE)","author":"Liddle","year":"1996"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Schunemann","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib6","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1111\/j.1523-1755.2005.09428.x","article-title":"Calcification and cardiovascular problems in renal failure","volume":"94","author":"Ketteler","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10157-003-0260-0","article-title":"Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis","volume":"8","author":"Matsuoka","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2004070610","article-title":"Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study","volume":"16","author":"Kramer","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1523-1755.2005.00522.x","article-title":"Progression of coronary artery calcification in diabetics with and without chronic kidney disease","volume":"68","author":"Mehrotra","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1681\/ASN.2007121327","article-title":"When is it appropriate to order an ionized calcium?","volume":"19","author":"Calvi","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Guerin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib20","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1523-1755.2004.00590.x","article-title":"Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE Study)","volume":"65","author":"Qunibi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1523-1755.2004.00877.x","article-title":"A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States","volume":"66","author":"Manns","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2215\/CJN.03850907","article-title":"Battleground: chronic kidney disorders mineral and bone disease\u2014calcium obsession, vitamin D, and binder confusion","volume":"3","author":"Kovesdy","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.ajkd.2008.01.004","article-title":"Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice","volume":"51","author":"Winkelmayer","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib25","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.ki.5001599","article-title":"Circulating PTH molecular forms: what we know and what we don't","volume":"102","author":"D'Amour","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5414\/CNP67131","article-title":"Parathyroid hormone and large related C-terminal fragments increase at different rates with worsening of renal function in chronic kidney disease patients","volume":"67","author":"Donadio","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5001666","article-title":"Reversal of adynamic bone disease by lowering of dialysate calcium","volume":"70","author":"Haris","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib30","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfg595","article-title":"Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure","volume":"19","author":"Rix","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib33","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1046\/j.1523-1755.1999.07163.x","article-title":"Factors associated with calcification of the abdominal aorta in hemodialysis patients","volume":"71","author":"Kimura","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(87)91370-5","article-title":"Aortic and mitral valve calcification in patients with end-stage renal disease","volume":"2","author":"Maher","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.ki.5002412","article-title":"The fallacy of the calcium-phosphorus product","volume":"72","author":"O'Neill","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1196\/annals.1346.044","article-title":"Misconceptions about calcimimetics","volume":"1068","author":"Nemeth","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib38","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib40","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1681\/ASN.2007121320","article-title":"Cinacalcet reduces the set point of the PTH-calcium curve","volume":"19","author":"Valle","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib41","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib42","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ki.2008.35","article-title":"Vitamin D receptor activation and survival in chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/ncpendmet0898","article-title":"Does treatment with calcitriol improve survival in predialysis patients with chronic kidney disease?","volume":"4","author":"Patel","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib44","first-page":"302","article-title":"Renal bone disease, disorders of divalent ions, and nephrolithiasis","volume":"7","author":"Martin","year":"2008","journal-title":"NephSAP"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00774-007-0785-5","article-title":"Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients","volume":"26","author":"Doumouchtsis","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib46","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1515\/CCLM.2007.306","article-title":"Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure","volume":"45","author":"Shaarawy","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib47","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/ndt\/gfl567","article-title":"Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD)","volume":"22","author":"Fujii","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib48","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/ndt\/gfl104","article-title":"Effects of bisphosphonates on bone loss in the first year after renal transplantation\u2014a meta-analysis of randomized controlled trials","volume":"21","author":"Mitterbauer","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib49","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib50","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.ki.5002651","article-title":"What does serum fibroblast growth factor 23 do in hemodialysis patients?","volume":"73","author":"Emmett","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib52","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib53","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2009.01.003_bib54","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2215\/CJN.01150308","article-title":"Vitamin D and kidney disease","volume":"3","author":"Al-Badr","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929509000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929509000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T08:26:18Z","timestamp":1545294378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929509000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0270929509000047"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2009.01.003","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}